Cargando…

Quality of life associated with immunosuppressant treatment adherence in liver transplant recipients: A cross-sectional study

Purpose: Transplanted organ survival after solid organ transplantation highly correlates with the adherence levels of the patients to their immunosuppressive drugs. On the other hand, one of the main goals of liver transplantation is to increase the overall quality of life (QOL) for the patient. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafiekhani, Mojtaba, Shahabinezhad, Farbod, Tavakoli, Zahra, Tarakmeh, Tahereh, Haem, Elham, Sari, Negar, Nasirabadi, Shohreh, Dehghani, Masoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998979/
https://www.ncbi.nlm.nih.gov/pubmed/36909168
http://dx.doi.org/10.3389/fphar.2023.1051350
_version_ 1784903572150812672
author Shafiekhani, Mojtaba
Shahabinezhad, Farbod
Tavakoli, Zahra
Tarakmeh, Tahereh
Haem, Elham
Sari, Negar
Nasirabadi, Shohreh
Dehghani, Masoud
author_facet Shafiekhani, Mojtaba
Shahabinezhad, Farbod
Tavakoli, Zahra
Tarakmeh, Tahereh
Haem, Elham
Sari, Negar
Nasirabadi, Shohreh
Dehghani, Masoud
author_sort Shafiekhani, Mojtaba
collection PubMed
description Purpose: Transplanted organ survival after solid organ transplantation highly correlates with the adherence levels of the patients to their immunosuppressive drugs. On the other hand, one of the main goals of liver transplantation is to increase the overall quality of life (QOL) for the patient. This study is aimed to analyze the relationship between adherence and QOL in adult liver transplant recipients of the biggest liver transplant center in Asia. Methods: All of the included patients were older than 18 years and at least 6 months had passed from their liver transplantation. The adherence level was measured with BAASIS method and the QOL was assessed by SF-36 questionnaire in real-time interviews. The relationship between adherence and different aspects of QOL in addition to qualitative and quantitative influential factors on these two outcomes was calculated with statistical analysis. Results: Among the 122 included patients, 41% of the were categorized in the non-adherent group. The most important reasons for non-adherence in these patients included forgetfulness (62%), lack of medication (12%), financial problems for drug supply (9%), and side effects (2%). According to the results of the multivariate linear regression model, rejection was the only influential factor in the occurrence of non-adherence among patients (OR = 8.226 CI (1.404-48.196)). The overall mean QOL score of patients was reported 51.09 ± 21.86. The lowest is given to social functioning, while mental health has achieved the highest score. The mean QOL scores in different dimensions in patients with adherence were higher than non-adherents, which was only significant in mental health (p-value = 0.01). Additionally, in total scores related to Physical Composite Score (PSC) and Mental Composite Score (MCS), the mean MSC scores in adherent patients were significantly higher than non-adherent patients (p-value: 0.02). Although adherent patients have an overall greater QOL, the only meaningful effect on QOL total score was from income level. Conclusion: The overall QoL score has been in all parameters higher in the adherent group compared with non-adherent patients. The difference in QoL was most meaningfully significant in mental composite score among other parameters of QoL.
format Online
Article
Text
id pubmed-9998979
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99989792023-03-11 Quality of life associated with immunosuppressant treatment adherence in liver transplant recipients: A cross-sectional study Shafiekhani, Mojtaba Shahabinezhad, Farbod Tavakoli, Zahra Tarakmeh, Tahereh Haem, Elham Sari, Negar Nasirabadi, Shohreh Dehghani, Masoud Front Pharmacol Pharmacology Purpose: Transplanted organ survival after solid organ transplantation highly correlates with the adherence levels of the patients to their immunosuppressive drugs. On the other hand, one of the main goals of liver transplantation is to increase the overall quality of life (QOL) for the patient. This study is aimed to analyze the relationship between adherence and QOL in adult liver transplant recipients of the biggest liver transplant center in Asia. Methods: All of the included patients were older than 18 years and at least 6 months had passed from their liver transplantation. The adherence level was measured with BAASIS method and the QOL was assessed by SF-36 questionnaire in real-time interviews. The relationship between adherence and different aspects of QOL in addition to qualitative and quantitative influential factors on these two outcomes was calculated with statistical analysis. Results: Among the 122 included patients, 41% of the were categorized in the non-adherent group. The most important reasons for non-adherence in these patients included forgetfulness (62%), lack of medication (12%), financial problems for drug supply (9%), and side effects (2%). According to the results of the multivariate linear regression model, rejection was the only influential factor in the occurrence of non-adherence among patients (OR = 8.226 CI (1.404-48.196)). The overall mean QOL score of patients was reported 51.09 ± 21.86. The lowest is given to social functioning, while mental health has achieved the highest score. The mean QOL scores in different dimensions in patients with adherence were higher than non-adherents, which was only significant in mental health (p-value = 0.01). Additionally, in total scores related to Physical Composite Score (PSC) and Mental Composite Score (MCS), the mean MSC scores in adherent patients were significantly higher than non-adherent patients (p-value: 0.02). Although adherent patients have an overall greater QOL, the only meaningful effect on QOL total score was from income level. Conclusion: The overall QoL score has been in all parameters higher in the adherent group compared with non-adherent patients. The difference in QoL was most meaningfully significant in mental composite score among other parameters of QoL. Frontiers Media S.A. 2023-02-24 /pmc/articles/PMC9998979/ /pubmed/36909168 http://dx.doi.org/10.3389/fphar.2023.1051350 Text en Copyright © 2023 Shafiekhani, Shahabinezhad, Tavakoli, Tarakmeh, Haem, Sari, Nasirabadi and Dehghani. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Shafiekhani, Mojtaba
Shahabinezhad, Farbod
Tavakoli, Zahra
Tarakmeh, Tahereh
Haem, Elham
Sari, Negar
Nasirabadi, Shohreh
Dehghani, Masoud
Quality of life associated with immunosuppressant treatment adherence in liver transplant recipients: A cross-sectional study
title Quality of life associated with immunosuppressant treatment adherence in liver transplant recipients: A cross-sectional study
title_full Quality of life associated with immunosuppressant treatment adherence in liver transplant recipients: A cross-sectional study
title_fullStr Quality of life associated with immunosuppressant treatment adherence in liver transplant recipients: A cross-sectional study
title_full_unstemmed Quality of life associated with immunosuppressant treatment adherence in liver transplant recipients: A cross-sectional study
title_short Quality of life associated with immunosuppressant treatment adherence in liver transplant recipients: A cross-sectional study
title_sort quality of life associated with immunosuppressant treatment adherence in liver transplant recipients: a cross-sectional study
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998979/
https://www.ncbi.nlm.nih.gov/pubmed/36909168
http://dx.doi.org/10.3389/fphar.2023.1051350
work_keys_str_mv AT shafiekhanimojtaba qualityoflifeassociatedwithimmunosuppressanttreatmentadherenceinlivertransplantrecipientsacrosssectionalstudy
AT shahabinezhadfarbod qualityoflifeassociatedwithimmunosuppressanttreatmentadherenceinlivertransplantrecipientsacrosssectionalstudy
AT tavakolizahra qualityoflifeassociatedwithimmunosuppressanttreatmentadherenceinlivertransplantrecipientsacrosssectionalstudy
AT tarakmehtahereh qualityoflifeassociatedwithimmunosuppressanttreatmentadherenceinlivertransplantrecipientsacrosssectionalstudy
AT haemelham qualityoflifeassociatedwithimmunosuppressanttreatmentadherenceinlivertransplantrecipientsacrosssectionalstudy
AT sarinegar qualityoflifeassociatedwithimmunosuppressanttreatmentadherenceinlivertransplantrecipientsacrosssectionalstudy
AT nasirabadishohreh qualityoflifeassociatedwithimmunosuppressanttreatmentadherenceinlivertransplantrecipientsacrosssectionalstudy
AT dehghanimasoud qualityoflifeassociatedwithimmunosuppressanttreatmentadherenceinlivertransplantrecipientsacrosssectionalstudy